Showing results (1561-1570 of 3,095) with videos related to

Sort By:
Pageof 310
Clinical Kidney Journal|December 12, 2024
Kidney transplantation in patients with polycystic kidney disease: increased risk of infection does not compromise graft and patient survivalJohannes Waiser, Jens Klotsche, Petra Glander, et al.
Clinical Kidney Journal|December 12, 2024
Diagnostic validity and solute-corrected prevalence for hyponatremia and hypernatremia among 1 813 356 admissionsAkira Okada, Hayato Yamana, Hideaki Watanabe, et al.
Clinical Kidney Journal|December 12, 2024
Adult-onset female focal segmental glomerulosclerosis with nephrotic syndrome caused by a TBC1D8B variant: a case reportXiaoying Hu, Wenrong Cheng, Xiaoyi Xu, et al.
Clinical Kidney Journal|December 16, 2024
Does de novo malignancy heighten the risk of rejection in kidney transplant recipients?Erol Demir, Mevlut Tamer Dincer, Cebrail Karaca, et al.
Clinical Kidney Journal|November 14, 2024
Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective studySarinya Boongird, Thatsaphan Srithongkul, Sethanant Sethakarun, et al.
Clinical Kidney Journal|November 11, 2024
Severe hypophosphatemia induced by excessive production of FGF23 in acute hepatitis: from bedside to benchAghiles Hamroun, Nihad Boukrout, Christelle Cauffiez, et al.
Clinical Kidney Journal|February 20, 2025
Synergistic effect of teclistamab with PD-1 inhibition: a case of acute interstitial nephritis with dual immunotherapyArjunmohan Mohan, Elena-Bianca Barbir, Loren Herrera Hernandez, et al.
Clinical Kidney Journal|February 19, 2025
Factors influencing early response of IgA nephropathy following targeted-release budesonide (TRB) treatment: preliminary results from a multicenter studyChristodoulos Keskinis, Eleni Moysidou, Eleni Kapsia, et al.
Clinical Kidney Journal|November 7, 2024
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemicMingyue Xu, Ruiying Chen, Yifeng Wang, et al.
Clinical Kidney Journal|November 6, 2025
Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL studyTilla C Folttmann, Antje M Haas, Nicholas C Chesnaye, et al.
Pageof 310